Chemistry: natural resins or derivatives; peptides or proteins; – Proteins – i.e. – more than 100 amino acid residues – Blood proteins or globulins – e.g. – proteoglycans – platelet...
Reexamination Certificate
2011-06-28
2011-06-28
Kim, Taeyoon (Department: 1651)
Chemistry: natural resins or derivatives; peptides or proteins;
Proteins, i.e., more than 100 amino acid residues
Blood proteins or globulins, e.g., proteoglycans, platelet...
C514S013600, C514S014700, C424S094640, C435S214000
Reexamination Certificate
active
07968682
ABSTRACT:
Provided are degradation-resistant fibrinogen sealants comprising a first composition comprising one or more of fibrinogen γA/γ′ heterodimers and/or fibrinogen γ′/γ′ homodimers and a second composition comprising thrombin and, optionally, degradation-resistant fibrinogen sealants disclosed herein may further comprise Factor XIII and calcium. Degradation-resistant fibrinogen sealants are suitable for the treatment of trauma, particularly vascular trauma.
REFERENCES:
patent: 5739288 (1998-04-01), Edwardson et al.
Collet et al. 2004. Influence of gamma' Fibrinogen Splice Variant on Fibrin Physical Properties and Fibrinolysis Rate. Arterioscler. Thromb. Vasc. Biol. 24:382-386.
Falls et al. 1997. Resistance of gammaA/gamma' Fibrin Clots to Fibrinolysis. J. Biol. Chem. vol. 272, No. 22, pp. 14251-14256.
Buchta et al. 2005. Biochemical characterization of autologous fibrin sealants produced by CryoSeals and Vivostats in comparison to the homologous fibrin sealant product Tissucol/Tisseels. Biomaterials 26:6233-6241.
Tisseel VH Fibrin Sealant Two-Component Fibrin Sealant, Vapor Heated, Kit. 2003. Baxter Healthcare Corp. p. 1-3.
Moaddel, M., et al. “Interactions of human fibrinogens with factor XIII: roles of calcium and the gamma' peptide.” Biochemistry. Jun. 6, 2000;39(22):6698-705.
Lovely, R.S., et al. “Association of gammaA/gamma' fibrinogen levels and coronary artery disease.” Thromb Haemost. Jul. 2002;88(1):26-31.
Lovely, R.S., et al. “Fibrinogen gamma' chain binds thrombin exosite II.” J Thromb Haemost. Jan. 2003;1(1):124-31.
Moaddel, M., et al. “The role of gamma A/gamma ' fibrinogen in plasma factor XIII activation.” J Biol Chem. Oct. 13, 2000;275(41):32135-40.
Siebenlist, K.R., et al. “Studies on the basis for the properties of fibrin produced from fibrinogen-containing gamma' chains.” Blood. Oct. 15, 2005;106(8):2730-6. Epub Jul. 7, 2005.
Podor, T.J., et al. “Incorporation of vitronectin into fibrin clots. Evidence for a binding interaction between vitronectin and gamma A/gamma' fibrinogen.” J Biol Chem. Mar. 1, 2002;277(9):7520-8. Epub Dec. 14, 2001.
Siebenlist, K.R. “Response: Fibrinogen containing gamma' chains.” Blood. Apr. 1, 2006;107(7):3011-2; author reply 3012.
Farrell, D.H. “Fibrinogen containing gamma' chains.” Blood. Apr. 1, 2006;107(7):3011-2; author reply 3012.
Farrell, D.H. “Pathophysiologic roles of the fibrinogen gamma chain.” Curr Opin Hematol. May 2004;11(3):151-5.
Dann Dorfman Herrell & Skillman
Kim Taeyoon
Netter, Jr. Robert C.
Oregon Health & Science University
LandOfFree
Degradation-resistant fibrinogen sealants does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Degradation-resistant fibrinogen sealants, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Degradation-resistant fibrinogen sealants will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2717591